Chaga
Inonotus obliquus
TL;DR
Chaga is one of the highest-antioxidant fungal extracts by lab assay, but there are essentially no controlled human trials. Its high oxalate content is a genuine kidney risk at heavy daily doses.
Ideal For
- People who enjoy functional mushroom teas and have healthy kidneys
- Those seeking a beta-glucan source with realistic expectations
Avoid If
- You have kidney disease or a history of calcium oxalate stones
- You take warfarin or another anticoagulant
- You are pregnant or breastfeeding
- You would be taking multiple grams daily for months
Frequently Asked Questions
Overview
Chaga (Inonotus obliquus) is a sterile conk that grows on birch trees, harvested as a hard black mass and brewed as tea or extracted for capsules. Its composition is unusual: melanin, betulin and betulinic acid absorbed from the host birch, plus beta-glucans and triterpenes. Laboratory work shows very high ORAC values, inhibition of NF-kB, and immunomodulatory effects on macrophages, and animal models suggest anti-inflammatory and glucose-lowering activity. What is missing is human data: as of now there are no adequately powered randomised controlled trials in people for immunity, cancer, fatigue or blood sugar, so every clinical claim is extrapolation. Two practical issues matter more than the mechanistic promise. First, chaga is very high in oxalate, and case reports document oxalate nephropathy and end-stage renal failure after months of heavy daily consumption. Second, wild harvesting is depleting birch populations, and much commercial powder is mycelium grown on grain rather than true sclerotium. Reasonable use is occasional tea in people with normal kidney function, not high-dose daily powder.
How It Works
- Beta-glucans engage dectin-1 receptors on macrophages and dendritic cells
- Polyphenol and melanin content drives high in-vitro antioxidant capacity
- Betulinic acid shows pro-apoptotic activity in cancer cell lines (preclinical only)
- Inhibits NF-kB-mediated inflammatory signalling in cell models
Health Concerns Addressed
No linked health concerns yet.
Supporting Research8 studies
Therapeutic properties of Inonotus obliquus (Chaga mushroom): A review
Tee Yon Ern P, Tang YQ, Fung SY +1 more
Chaga polysaccharides and triterpenoids show antioxidant, immunomodulatory and antitumour activity in cell and animal models, but controlled human trials are essentially absent.
Chaga mushroom-induced oxalate nephropathy
Kikuchi Y, Seta K, Ogawa Y +2 more
This is the first report of a case of oxalate nephropathy associated with ingestion of Chaga mushrooms.
Development of End Stage Renal Disease after Long-Term Ingestion of Chaga Mushroom: Case Report and Review of Literature
Kwon Y, et al.
A patient developed end-stage renal disease with biopsy findings of oxalate crystal deposition after taking chaga mushroom powder daily for six months.
A review on the cultivation, bioactive compounds, health-promoting factors and clinical trials of medicinal mushrooms Taiwanofungus camphoratus, Inonotus obliquus and Tropicoporus linteus
Tee PYE, Krishnan T, Cheong XT +2 more
Evidence of the robust pharmacological properties, including their anticancer, hypoglycemic, hypolipidemic, antioxidant, and antiviral activities, have been provided in various studies.
Chaga mushroom-induced oxalate nephropathy that clinically manifested as nephrotic syndrome
Lee S, et al.
Biopsy-confirmed oxalate nephropathy developed after regular chaga mushroom powder consumption, presenting as nephrotic-range proteinuria and acute kidney injury.
Inonotus obliquus - from folk medicine to clinical use
Szychowski KA, Skóra B, Pomianek T +1 more
The most promising finding was the demonstration that I. obliquus has hypoglycemic and insulin sensitivity potential.
Preparation, bioactivities, structure-activity relationships, applications, and safety concerns of Inonotus obliquus polysaccharides: A review
Cui M, Wang X, Yu T +2 more
Inonotus obliquus polysaccharides (IOPs) are beta-glucan-rich heteropolysaccharides whose structural diversity underlies their immunomodulatory, antioxidant, and gut-organ-axis-mediated activities.
Recent Developments in Inonotus obliquus (Chaga mushroom) Polysaccharides: Isolation, Structural Characteristics, Biological Activities and Application
Lu Y, Jia Y, Xue Z +2 more
Inonotus obliquus polysaccharide (IOPS) is supposed to be one of the major bioactive components in Inonotus obliquus, which possesses antitumor, antioxidant, anti-virus, hypoglycemic, and hypolipidemic activities.
Safety Information
Potential Side Effects
Usually well tolerated short term. Oxalate nephropathy reported with prolonged heavy use.
Contraindications
Chronic kidney disease, kidney stones, or reduced eGFR.
Drug Interactions
- Anticoagulants and antiplatelets (antiplatelet activity in vitro)
- Antidiabetic drugs (possible additive glucose lowering)
- Immunosuppressants
Pregnancy & Breastfeeding
Pregnancy: insufficient_data
Breastfeeding: insufficient_data
Dosage Guidelines
Dosage Used in Studies
1-3 g
Best Time to Take
Morning as tea, not continuously long term
Best Form
Hot-water dual-extract from true sclerotium, not grain-grown mycelium
Forms Compared
Traditional; hot water extracts beta-glucans
Captures both beta-glucans and triterpenes
Common and cheap but mostly starch; check for sclerotium
Food & Timing
Any time; drink plenty of water.
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.